PBS Biotech Raises $22M to Expand Single-Use Manufacturing Products and Services for Cell Therapy Clients

Date Published01/08/2023
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name PBS Biotech
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Capital investment ($):22
City reshored to:Camarillo,
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredallogeneic cell-based therapies
What domestic positive factors made reshoring more attractive?Eco-system synergies, Under-utilized capacity
Find Reshoring Articles